New US nod for Roche's Tecentriq in NSCLC
admin 19th May 2020 Uncategorised 0This is Tecentriq’s fourth indication in metastatic non-small cell lung cancer and fifth indication in lung cancer overall in the US
More: New US nod for Roche's Tecentriq in NSCLC
Source: News
